Iván Marcipar

Comparison of Recombinant <i>Trypanosoma cruzi</i> Peptide Mixtures versus Multiepitope Chimeric Proteins as Sensitizing Antigens for Immunodiagnosis

Cecilia Camussone, Verónica Gonzalez, María Soledad Belluzo et al. · Clinical and Vaccine Immunology · 2009 · 74 citations · Full text

The Value of Molecular Studies for the Diagnosis of Congenital Chagas Disease in Northeastern Argentina

Cristina Noemí Diez, Silvia Manattini, J C Zanuttini et al. · American Journal of Tropical Medicine and Hygiene · 2008 · 51 citations · Full text

Month 2, Polymerase Chain Reaction, Parasitic Disease +12

Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease

Iván Bontempi, Miguel Hernán Vicco, Gabriel Cabrera et al. · Vaccine · 2015 · 45 citations

Vaccinology, Vaccination, Vaccine Development +8

Performance of different <i><scp>T</scp>rypanosoma cruzi</i> antigens in the diagnosis of <scp>C</scp>hagas disease in patients with <scp>A</scp>merican cutaneous leishmaniasis from a co‐endemic region in <scp>A</scp>rgentina

Ana Florencia Vega-Benedetti, Rubén O. Cimino, Pamela Cajal et al. · Tropical Medicine & International Health · 2013 · 33 citations · Full text

Trans-sialidase-based vaccine candidate protects against <i>Trypanosoma cruzi</i> infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype

Estefanía Prochetto, Carolina Roldán, Iván Bontempi et al. · Oncotarget · 2017 · 33 citations · Full text